Manufacturing processes for gene therapy products are generally low yielding compared to production processes for other biologics.
Watch Now
Engineered T cells expressing high-affinity chimeric antigen receptors (CARs) confer remarkable tumor specificity by recognizing patient-specific tumor antigens and triggering antitumor activities.
Watch Now
Labroots
Human T cells are central effectors of immunity and cancer immunotherapy. CRISPR-based functional studies in T cells could prioritize novel targets for drug development and improve the design of genetically reprogrammed cell-based therapies.
Watch Now
In this webinar, Dr. Wen introduces LIDE Biotech and their range of available services which include personalized oncology. For example, LIDE utilizes next generation sequencing (NGS) or polymerase chain reaction (PCR) testing in cases where driver genes are clearly identified and functional diagnostics in instances where driver genes are unclear. In addition, they offer drug research and development services, from preclinical testing through clinical trials.
Watch Now